Idiopathic Hypersomnia and Other Hypersomnia Syndromes Essay
Idiopathic Hypersomnia and Other Hypersomnia Syndromes Essay
DSM-5 Criteria Of Hypersomnia
Hypersomnia is defined as self-reported excessive sleepiness despite the sleep lasting for over 7hours (Trotti, & Arnulf, 2020). The DSM-5 criteria for making the diagnosis states that hypersomnia may be associated with a recurrent period of sleep lapses within the same day, a prolonged main sleep episode lasting over 9hours, and difficulties of being fully awake after an abrupt awakening (Khaled, et al, 2020). Other factors that meet the criteria are; hype somnolence that occurs at least three times a week for three months. Hype somnolence associated with significant distress or impaired cognitive, social, or occupational functioning meets the criteria for hypersomnia. Hype somnolence is not attributable to physiological effects of a substance, coexisting mental disorder, or medical condition. Idiopathic Hypersomnia and Other Hypersomnia Syndromes Essay
Evidence-Based Pharmacological And Psychotherapy Treatment Of Hypersomnia
BUY NOW A PLAGIARISM-FREE PAPER HERE
The American Academy of sleep medicine states that psychotherapeutic and pharmacological approaches relieve hypersomnia. The pharmacological approach involves giving medicine or stimulants such as modafinil 200mg orally in the morning (Morton, & Murray, 2020). Modafinil is a wake-promoting agent recommended for treating excessive sleepiness associated with narcolepsy, and obstructive sleep apnea. The psychotherapy approach in treating hypersomnia as recommended by the American Academy of sleep medicine involves both psychological and behavioral interventions. For example, cognitive behavioral therapy helps to change the patient’s behavior and improve sleep hygiene techniques. Idiopathic Hypersomnia and Other Hypersomnia Syndromes Essay
Risks Of Different Type Of Therapy And How The Benefits Of The Therapy Outweigh The Risks
Therapeutic modalities for hypersomnia are pharmacotherapy and psychotherapy. Pharmacotherapy involves giving medicine (stimulants) to keep the patient awake the whole day. The pharmacotherapeutic approach is risky because it may cause dependence or addiction, drug adverse effects may cause death, and non-compliance to medication may deteriorate the condition (Morton, & Murray, 2020). Patients undergoing psychotherapy fail to comply with the sessions or do not follow the guidance given. Thus, it causes deterioration of the disease. Despite the risks involved, the patient should undergo both therapies to reduce hype somnolence. Idiopathic Hypersomnia and Other Hypersomnia Syndromes Essay
• Explain the DSM-5 criteria for Hypersomnia • Explain the evidenced-based psychotherapy and psychopharmacologic treatment for your assigned neurocognitive disorder. • Identify the risks of different types of therapy and explain how the benefits of the therapy that might be achieved might outweigh the risks.
References
Khaled, S. M., Petcu, C., Al-Thani, M. A., Al-Hamadi, A. M. H., Daher-Nashif, S., Zolezzi, M., & Woodruff, P. (2021). Prevalence and associated factors of DSM-5 insomnia disorder in the general population of Qatar. BMC psychiatry, 21(1), 1-10.
Morton, & Murray, (2020). Assessment and treatment of sleep problems in bipolar disorder—A guide for psychologists and clinically focused review. Clinical psychology & psychotherapy, 27(3), 364-377.
Trotti, & Arnulf, (2020). Idiopathic Hypersomnia and Other Hypersomnia Syndromes. Neurotherapeutics, 1-12. Idiopathic Hypersomnia and Other Hypersomnia Syndromes Essay
